Cyfuse Biomedical KK (4892) Stock Price & News

All values in JPY	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	32.00M	169.00M	28.00M	76.00M
Cost of goods sold	21.00M	81.00M	8.00M	31.00M
Cost of revenue	21.00M	81.00M	8.00M	31.00M
Research and development expenses	-	416.00M	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	230.00M	-203.00M	236.00M	246.00M
Operating expense	230.00M	227.00M	236.00M	246.00M
Total operating expenses	251.00M	308.00M	244.00M	277.00M
Operating income	-219.00M	-139.00M	-216.00M	-201.00M
Other non operating income	-14.00M	20.00M	-3.00M	-5.00M
EBT including unusual items	-235.00M	-125.00M	-224.00M	-209.00M
EBT excluding unusual items	-235.00M	-125.00M	-224.00M	-209.00M
Income tax expense	-	1.00M	-	1.00M
Effective tax rate	-	-0.80%	-	-0.48%
Other operating expenses	-	-	-	-
Net income	-235.00M	-126.00M	-224.00M	-210.00M
Net profit margin	-734.38%	-74.56%	-800.00%	-276.32%
Earnings per share	-	-	-	-
Interest and investment income	2.00M	-	1.00M	2.00M
Interest expense	-4.00M	-6.00M	-6.00M	-5.00M
Net interest expenses	-2.00M	-6.00M	-5.00M	-3.00M
Depreciation and amortization charges	-	14.00M	-	-
EBITDA	-209.50M	-129.75M	-206.75M	-194.50M
Gain or loss from assets sale	-	-	-	-

Finance